A significant breakthrough in cancer study is occurring with the use of mini-antibodies to re-engage mutated p53. This vital malignant protector protein is frequently disabled in several kinds of tumors, resulting https://thebookmarklist.com/story21911188/vhh-fragments-reactivate-the-p53-protein-new-new-approach-for-tumor-treatment